What is the recommended dose of Bromfed DM (Brompheniramine, Dextromethorphan) for a 5-year-old child?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: January 22, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Bromfed DM Should Not Be Used in a 5-Year-Old Child

The FDA and major pediatric organizations do not recommend over-the-counter cough and cold medications containing brompheniramine and dextromethorphan for children under 6 years of age due to lack of proven efficacy and significant safety concerns, including fatal toxicity cases. There is no established safe pediatric dosing for Bromfed DM in this age group.

Critical Safety Concerns

Lack of Efficacy and Safety Data

  • No proven benefit exists for dextromethorphan in treating cough in young children, and its use is not supported by the American Academy of Pediatrics 1
  • Brompheniramine has not been adequately studied for safety and efficacy in children under 6 years of age 2
  • Fatal intoxications have been documented in infants receiving combination products containing brompheniramine and dextromethorphan, even at doses that might appear therapeutic 3

Age-Specific Contraindications

  • Children under 6 years should not receive over-the-counter cough and cold combination products due to the risk of serious adverse events including death 3
  • The pharmacokinetic parameters in young children differ substantially from adults, making standard dosing inappropriate and potentially dangerous 4

Why This Medication Is Problematic for Young Children

Unpredictable Dosing

  • Current manufacturer dosing recommendations are based on age rather than weight, resulting in substantial variability in actual drug exposure (ranging from 0.35 to 0.94 mg/kg for dextromethorphan) 1
  • This age-based approach fails to account for individual pharmacokinetic differences in young children 4

Documented Toxicity

  • A fatal case involved an infant with blood concentrations of brompheniramine at 0.40 mg/L and dextromethorphan at 0.50 mg/L, demonstrating the narrow margin of safety in young children 3
  • Adverse events occur more frequently with higher doses, but even "therapeutic" doses can be problematic 1

Recommended Alternatives

Supportive Care Measures

  • Use humidified air and adequate hydration for symptomatic relief of upper respiratory symptoms
  • Elevate the head of the bed to reduce nocturnal cough
  • Consider honey (for children over 1 year) as a natural cough suppressant with better evidence of efficacy than over-the-counter medications

When to Seek Medical Evaluation

  • If symptoms persist beyond 7-10 days or worsen
  • If fever exceeds 72 hours or is accompanied by respiratory distress
  • If the child appears systemically ill or has difficulty breathing

Common Pitfall to Avoid

Do not calculate a "pediatric dose" based on adult dosing or weight-based extrapolation for this combination product in children under 6 years. The absence of dosing guidelines reflects genuine safety concerns rather than a gap in knowledge that can be filled by calculation 4, 3.

References

Research

The clinical pharmacology of brompheniramine in children.

The Journal of allergy and clinical immunology, 1999

Research

Fatal cold medication intoxication in an infant.

Journal of analytical toxicology, 2003

Research

Dosing considerations in the pediatric patient.

Clinical therapeutics, 1991

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.